Settlement rails and data infrastructure built for biotech capital
Two purpose-built platforms sharing a single operational integration layer—one handling capital settlement velocity, one structuring healthcare data as a financeable asset.
Capital flows at settlement speed
Healthcare data structured as capital
Hong Kong-native reconciliation infrastructure purpose-built for biotech capital flows: T+0 intraday settlement windows, regulatory-compliant audit trails under HKMA frameworks, and automated matching across multi-currency biotech funding rounds.
Clinical trial datasets, regulatory dossiers, and lab-generated data are ingested, normalized, and structured to capital-grade standards—making them auditable as collateral assets rather than isolated compliance artefacts.
Operational integration connects directly to existing ERP and treasury systems—no rip-and-replace, no parallel reconciliation overhead.
The same integration layer that feeds settlement rails reads directly from lab information management systems, closing the loop between bench output and financing event.
T+0 intraday settlement
Single integration layer
HKMA-compliant audit trail
One operational API surface connects ERP, LIMS, and settlement rails—eliminating the coordination overhead between finance and lab operations.
Regulatory rigor is built into the data pipeline—every capital event carries a complete, examiner-ready audit record from first data ingestion.
Biotech capital flows reconciled within the same trading session—no overnight exposure, no manual matching queues.
Evaluate architectural fit before any sales conversation
We run structured technical briefings for CTOs and CFOs. Bring your integration constraints and settlement workflow—we'll map the gap in the first session.